Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma.

Hsu PK, Chen HY, Yeh YC, Yen CC, Wu YC, Hsu CP, Hsu WH, Chou TY.

J Gastroenterol. 2014 Aug;49(8):1231-40. doi: 10.1007/s00535-013-0870-6. Epub 2013 Aug 21.

PMID:
23963785
2.

Upregulation of the TPX2 gene is associated with enhanced tumor malignance of esophageal squamous cell carcinoma.

Liu HC, Zhang Y, Wang XL, Qin WS, Liu YH, Zhang L, Zhu CL.

Biomed Pharmacother. 2013 Oct;67(8):751-5. doi: 10.1016/j.biopha.2013.04.004. Epub 2013 May 14.

PMID:
23725757
4.

Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.

Hsu PK, Kao HL, Chen HY, Yen CC, Wu YC, Hsu WH, Chou TY.

J Thorac Cardiovasc Surg. 2014 May;147(5):1612-1618.e4. doi: 10.1016/j.jtcvs.2013.09.066. Epub 2013 Nov 19.

5.

The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.

Takahashi Y, Sheridan P, Niida A, Sawada G, Uchi R, Mizuno H, Kurashige J, Sugimachi K, Sasaki S, Shimada Y, Hase K, Kusunoki M, Kudo S, Watanabe M, Yamada K, Sugihara K, Yamamoto H, Suzuki A, Doki Y, Miyano S, Mori M, Mimori K.

Ann Oncol. 2015 May;26(5):935-42. doi: 10.1093/annonc/mdv034. Epub 2015 Jan 28.

PMID:
25632068
6.

TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.

Yang X, Liu G, Xiao H, Yu F, Xiang X, Lu Y, Li W, Liu X, Li S, Shi Y.

Pathol Oncol Res. 2014 Jul;20(3):641-8. doi: 10.1007/s12253-014-9743-4. Epub 2014 Feb 1.

PMID:
24488334
7.

Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.

Ma Y, Lin D, Sun W, Xiao T, Yuan J, Han N, Guo S, Feng X, Su K, Mao Y, Cheng S, Gao Y.

Clin Cancer Res. 2006 Feb 15;12(4):1121-7.

8.

The expression and role of Aquaporin 5 in esophageal squamous cell carcinoma.

Shimizu H, Shiozaki A, Ichikawa D, Fujiwara H, Konishi H, Ishii H, Komatsu S, Kubota T, Okamoto K, Kishimoto M, Otsuji E.

J Gastroenterol. 2014 Apr;49(4):655-66. doi: 10.1007/s00535-013-0827-9. Epub 2013 May 9.

PMID:
23657608
9.

An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.

Ito T, Hashimoto Y, Tanaka E, Kan T, Tsunoda S, Sato F, Higashiyama M, Okumura T, Shimada Y.

Clin Cancer Res. 2006 Feb 15;12(4):1308-16.

11.

Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.

Yu VZ, Wong VC, Dai W, Ko JM, Lam AK, Chan KW, Samant RS, Lung HL, Shuen WH, Law S, Chan YP, Lee NP, Tong DK, Law TT, Lee VH, Lung ML.

Gastroenterology. 2015 Dec;149(7):1825-1836.e5. doi: 10.1053/j.gastro.2015.08.025. Epub 2015 Aug 22.

PMID:
26302489
12.

Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.

PMID:
20108042
13.

Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.

Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Kidogami S, Miyata H, Takiguchi S, Fujiwara Y, Yasuda T, Yano M, Nakamori S, Sakon M, Monden M, Aozasa K.

Clin Cancer Res. 2004 Aug 15;10(16):5558-65.

14.

Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.

Cao X, Li Y, Luo RZ, He LR, Yang J, Zeng MS, Wen ZS.

Ann Thorac Surg. 2012 May;93(5):1674-80. doi: 10.1016/j.athoracsur.2011.12.056. Epub 2012 Mar 17.

PMID:
22429674
15.

Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.

Lee KW, Kim JH, Han S, Sung CO, Do IG, Ko YH, Um SH, Kim SH.

Ann Surg Oncol. 2012 Jan;19(1):326-35. doi: 10.1245/s10434-011-1867-0. Epub 2011 Jul 6.

PMID:
21732143
16.

Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.

Hibino S, Kanda M, Oya H, Takami H, Shimizu D, Nomoto S, Hishida M, Niwa Y, Koike M, Yamada S, Nishikawa Y, Asai M, Nakayama G, Fujii T, Sugimoto H, Fujiwara M, Kodera Y.

Oncol Rep. 2014 Feb;31(2):693-700. doi: 10.3892/or.2013.2901. Epub 2013 Dec 5.

PMID:
24317529
17.

Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.

Luo KJ, Wen J, Xie X, Fu JH, Luo RZ, Wu QL, Hu Y.

Ann Thorac Surg. 2012 May;93(5):1682-8. doi: 10.1016/j.athoracsur.2012.01.102. Epub 2012 Apr 4.

PMID:
22480390
18.

Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma.

Li X, Wu Z, Mei Q, Li X, Guo M, Fu X, Han W.

Br J Cancer. 2013 Oct 15;109(8):2266-78. doi: 10.1038/bjc.2013.548. Epub 2013 Sep 10.

19.

Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.

Zhang G, Zhang Q, Zhang Q, Yin L, Li S, Cheng K, Zhang Y, Xu H, Wu W.

J Cancer Res Clin Oncol. 2010 Apr;136(4):587-94. doi: 10.1007/s00432-009-0693-2. Epub 2009 Oct 13.

PMID:
19823871
20.

High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.

Huang ZL, Lin ZR, Xiao YR, Cao X, Zhu LC, Zeng MS, Zhong Q, Wen ZS.

Oncotarget. 2015 Mar 30;6(9):6850-61.

Supplemental Content

Support Center